• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

用伊维菌素缓释剂、浇泼剂或注射剂治疗奶牛后,伊维菌素在血浆和粪便中的残留情况。

Persistence of ivermectin in plasma and faeces following treatment of cows with ivermectin sustained-release, pour-on or injectable formulations.

作者信息

Herd R P, Sams R A, Ashcraft S M

机构信息

College of Veterinary Medicine, Ohio State University, Columbus 43210, USA.

出版信息

Int J Parasitol. 1996 Oct;26(10):1087-93.

PMID:8982789
Abstract

Sixteen young dairy cows were randomly allocated to 4 groups of 4 animals each: Group 1 cows were each given a single Ivomec SR Bolus; Group 2 cows were treated with the Ivomec Pour-on formulation; Group 3 cows were injected with the Ivomec Subcutaneous Injection; Group 4 cows were untreated controls. Blood and faecal samples were collected from all cows on the day before treatment and on days 1, 2, 3, 7, 14, 21, 28, 35, 42 and 49 after treatment for HPLC determination of plasma and faecal ivermectin concentrations. Group 1 (SR Bolus) cows had mean (+/- S.D.) plasma ivermectin concentrations ranging from 5.6 +/- 1.8 micrograms l-1 (p.p.b.) at 14 days to 11.0 +/- 4.7 micrograms l-1 at 49 days. Faecal ivermectin concentrations were little changed from 4.0 +/- 2.0 micrograms g-1 (p.p.m.) dry wt (dry weight) [0.5 +/- 0.2 microgram g-1 wet wt (wet weight)] at 14 days to 3.0 +/- 2.0 micrograms g-1 dry wt (0.5 +/- 0.4 microgram g-1 wet wt) at 49 days. Group 2 (Pour-on) cows showed a rapid rise in plasma concentrations to 32.9 +/- 15.7 micrograms l-1 2 days after treatment, followed by a gradual decline to 1.3 +/- 0.07 micrograms l-1 at 28 days. Faecal ivermectin concentrations rose sharply to 18.5 +/- 7.4 micrograms g-1 dry wt (2.8 +/- 1.2 micrograms g-1 wet wt) 2 days after treatment, then fell to 0.04 +/- 0.004 microgram g-1 dry wt (0.006 +/- 0.0004 microgram g-1 wet wt) at 28 days. Group 3 (Injection) cows also showed a rapid rise to an early plasma peak of 46.1 +/- 22.7 micrograms l-1 3 days after treatment, followed by a gradual decline to 1.3 micrograms l-1 at 35 days. Faecal ivermectin concentrations rose to 1.2 +/- 0.34 micrograms g-1 dry wt (0.2 +/- 0.05 microgram g-1 wet wt) at 3 days, declining to 0.08 +/- 0.0001 microgram g-1 dry wt (0.01 +/- 0.0008 microgram g-1 wet wt) at 28 days. No ivermectin was detected in the plasma or faeces of Group 4 (Control) cows. Concentrations of ivermectin potentially toxic to dung-breeding or dung-feeding invertebrates were excreted for the duration of the study in dung of cows treated with the SR Bolus and for 28 days in the dung of cows treated with the Pour-on or injectable formulations.

摘要

16头年轻奶牛被随机分为4组,每组4头:第1组奶牛每头注射一剂伊维菌素缓释丸剂;第2组奶牛用伊维菌素浇泼剂处理;第3组奶牛注射伊维菌素皮下注射液;第4组奶牛为未处理的对照组。在处理前一天以及处理后的第1、2、3、7、14、21、28、35、42和49天,从所有奶牛采集血液和粪便样本,用于高效液相色谱法测定血浆和粪便中伊维菌素的浓度。第1组(缓释丸剂)奶牛的血浆伊维菌素平均浓度(±标准差)在14天时为5.6±1.8微克/升(十亿分比),到49天时为11.0±4.7微克/升。粪便中伊维菌素浓度变化不大,从14天时的4.0±2.0微克/克干重(百万分比)[0.5±0.2微克/克湿重]到49天时的3.0±2.0微克/克干重(0.5±0.4微克/克湿重)。第2组(浇泼剂)奶牛在处理后2天血浆浓度迅速升至32.9±15.7微克/升,随后逐渐下降,到28天时降至1.3±0.07微克/升。粪便中伊维菌素浓度在处理后2天急剧升至18.5±7.4微克/克干重(2.8±1.2微克/克湿重),然后在28天时降至0.04±0.004微克/克干重(0.006±0.0004微克/克湿重)。第3组(注射剂)奶牛在处理后3天也迅速升至早期血浆峰值46.1±22.7微克/升,随后逐渐下降,到35天时降至1.3微克/升。粪便中伊维菌素浓度在3天时升至1.2±0.34微克/克干重(0.2±0.05微克/克湿重),在28天时降至0.08±0.0001微克/克干重(0.01±0.0008微克/克湿重)。第4组(对照组)奶牛的血浆或粪便中未检测到伊维菌素。在用缓释丸剂处理的奶牛粪便中,在整个研究期间都排泄出了对粪便繁殖或粪便摄食无脊椎动物具有潜在毒性的伊维菌素浓度;在用浇泼剂或注射剂处理的奶牛粪便中,在28天内排泄出了该浓度。

相似文献

1
Persistence of ivermectin in plasma and faeces following treatment of cows with ivermectin sustained-release, pour-on or injectable formulations.用伊维菌素缓释剂、浇泼剂或注射剂治疗奶牛后,伊维菌素在血浆和粪便中的残留情况。
Int J Parasitol. 1996 Oct;26(10):1087-93.
2
The negative effects of the residues of ivermectin in cattle dung using a sustained-release bolus on Aphodius constans (Duft.) (Coleoptera: Aphodiidae).使用缓释丸剂时牛粪中伊维菌素残留对康氏蜉金龟(达夫特)(鞘翅目:蜉金龟科)的负面影响。
Vet Res. 2001 Sep-Oct;32(5):421-7. doi: 10.1051/vetres:2001134.
3
Persistence of ivermectin in plasma and faeces following administration of a sustained-release bolus to cattle.给牛投喂缓释大丸剂后伊维菌素在血浆和粪便中的残留情况。
Res Vet Sci. 1999 Feb;66(1):57-61. doi: 10.1053/rvsc.1998.0240.
4
Faecal excretion profile of moxidectin and ivermectin after oral administration in horses.莫西菌素和伊维菌素经口给药后在马体内的粪便排泄情况
Vet J. 2001 Jan;161(1):85-92. doi: 10.1053/tvjl.2000.0521.
5
Plasma disposition and faecal excretion of eprinomectin following topical and subcutaneous administration in non-lactating dairy cattle.非泌乳奶牛经皮和皮下给药后,伊维菌素的血浆处置和粪便排泄情况。
N Z Vet J. 2016 Jul;64(4):207-11. doi: 10.1080/00480169.2016.1146172. Epub 2016 Feb 24.
6
A pharmacokinetic model to document the actual disposition of topical ivermectin in cattle.一个用于记录伊维菌素局部用药在牛体内实际处置情况的药代动力学模型。
Vet Res. 2003 Jul-Aug;34(4):445-60. doi: 10.1051/vetres:2003014.
7
Breed differences in the pharmacokinetics of ivermectin administered subcutaneously to Holstein and Belgian Blue calves.皮下注射伊维菌素后荷斯坦犊牛和比利时蓝牛犊牛药代动力学的品种差异
Vet Parasitol. 2008 Mar 25;152(1-2):136-40. doi: 10.1016/j.vetpar.2007.11.021. Epub 2007 Dec 4.
8
Ivermectin (3.15%) long-acting formulations in cattle: absorption pattern and pharmacokinetic considerations.牛用伊维菌素(3.15%)长效制剂:吸收模式及药代动力学考量
Vet Parasitol. 2007 Jul 20;147(3-4):303-10. doi: 10.1016/j.vetpar.2007.04.009. Epub 2007 May 23.
9
Sex-related plasma disposition of ivermectin following pour-on administration in goats.伊维菌素在山羊身上进行浇泼给药后的性别相关血浆处置情况。
Vet Parasitol. 2009 Jun 10;162(3-4):342-5. doi: 10.1016/j.vetpar.2009.03.004. Epub 2009 Mar 13.
10
Comparison of ivermectin SR bolus, benzimidazole anthelmintics, and topical fenthion on productivity of stocker cattle from grazing through feedlot.伊维菌素缓释大丸剂、苯并咪唑驱虫药和外用倍硫磷对放牧育肥牛在育肥场生产性能的比较。
Vet Ther. 2000 Summer;1(3):192-8.

引用本文的文献

1
Context-Dependent Effects of Ivermectin Residues on Dung Insects: Interactions With Environmental Stressors, Size, and Sex in a Sepsid Fly ().伊维菌素残留对粪栖昆虫的环境依赖性影响:与一种蚤蝇的环境应激源、体型及性别的相互作用
Ecol Evol. 2025 Aug 8;15(8):e71929. doi: 10.1002/ece3.71929. eCollection 2025 Aug.
2
Comparative susceptibility of wild and laboratory-reared Aedes and Anopheles larvae to ivermectin.野生和实验室饲养的伊蚊和按蚊幼虫对伊维菌素的敏感性比较。
Malar J. 2025 Jul 8;24(1):222. doi: 10.1186/s12936-025-05470-y.
3
Direct and Indirect Effects of Ivermectin on Phytophagous, Frugivorous and Parasitoid Insects.
伊维菌素对植食性、食果性和寄生性昆虫的直接和间接影响。
Insects. 2025 Apr 1;16(4):366. doi: 10.3390/insects16040366.
4
Evaluating the Human Risks of Consumption of Foods of Bovine Origin with Ivermectin Residues in Ecuador.评估厄瓜多尔食用含有伊维菌素残留的牛源性食品对人类的风险。
Foods. 2024 Oct 29;13(21):3470. doi: 10.3390/foods13213470.
5
Effects of ivermectin on development of Calliphora vicina, Robineau-Desvoidy 1830 (Diptera, Calliphoridae).伊维菌素对丽蝇科 Calliphora vicina Robineau-Desvoidy 1830(双翅目)发育的影响。
Parasitol Res. 2024 May 15;123(5):211. doi: 10.1007/s00436-024-08233-x.
6
Diseases of Iberian ibex ().伊比利亚野山羊的疾病()。
Eur J Wildl Res. 2023;69(3):63. doi: 10.1007/s10344-023-01684-0. Epub 2023 Jun 1.
7
An Update on Cephenemyiosis in the European Roe Deer: Emergent Myiasis in Spain.欧洲狍鹿脑包虫病的最新情况:西班牙出现的蝇蛆病
Animals (Basel). 2021 Nov 26;11(12):3382. doi: 10.3390/ani11123382.
8
The Pattern of Blood-Milk Exchange for Antiparasitic Drugs in Dairy Ruminants.反刍动物乳制品中抗寄生虫药物的血乳交换模式
Animals (Basel). 2021 Sep 22;11(10):2758. doi: 10.3390/ani11102758.
9
Current therapeutic applications and pharmacokinetic modulations of ivermectin.伊维菌素的当前治疗应用及药代动力学调节
Vet World. 2019 Aug;12(8):1204-1211. doi: 10.14202/vetworld.2019.1204-1211. Epub 2019 Aug 8.
10
First assessment of the comparative toxicity of ivermectin and moxidectin in adult dung beetles: Sub-lethal symptoms and pre-lethal consequences.伊维菌素和莫昔克丁对成年蜣螂比较毒性的首次评估:亚致死症状和致死前后果。
Sci Rep. 2018 Oct 5;8(1):14885. doi: 10.1038/s41598-018-33241-0.